| Automatic detection and segmentation of brain metastases on multimodal MR images with a deep convolutional neural network O Charron, A Lallement, D Jarnet, V Noblet, JB Clavier, P Meyer Computers in biology and medicine 95, 43-54, 2018 | 265 | 2018 |
| Enrollment of non-white participants and reporting of race and ethnicity in phase III trials of multiple sclerosis DMTs: a systematic review HM Onuorah, O Charron, E Meltzer, A Montague, A Crispino, A Largent, ... Neurology 98 (9), e880-e892, 2022 | 36 | 2022 |
| Microglia activation in basal ganglia is a late event in Huntington disease pathophysiology NP Rocha, O Charron, LB Latham, GD Colpo, P Zanotti-Fregonara, M Yu, ... Neurology: Neuroimmunology & Neuroinflammation 8 (3), e984, 2021 | 30 | 2021 |
| Cerebral blood flow is associated with markers of neurodegeneration in Huntington’s disease NP Rocha, O Charron, GD Colpo, LB Latham, JE Patino, EF Stimming, ... Parkinsonism & Related Disorders 102, 79-85, 2022 | 2 | 2022 |
| Prediction of disability and treatment response from radiomic features: a machine learning analysis from the combirx multi-center cohort K Wahid, O Charron, R Colen, RT Shinohara, A Kotrotsou, ... ACTRIMS Forum 2019, 2019 | 1 | 2019 |
| Correcting synthetic MRI contrast-weighted images using deep learning S Kumar, H Saber, O Charron, L Freeman, JI Tamir Magnetic Resonance Imaging 106, 43-54, 2024 | | 2024 |
| Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study E Meltzer, O Charron, J Wozny, H Onuorah, A Montague, AC Kline, ... Multiple Sclerosis and Related Disorders 80, 105085, 2023 | | 2023 |
| Risk of Relapse and Sustained Disability Progression in People with MS during the COVID-19 Pandemic E Huson, O Charron, D Andino, A Montague, AC Kline, J Wozny, ... MULTIPLE SCLEROSIS JOURNAL 29, 457-458, 2023 | | 2023 |
| Therapeutic efficacy of MRI: association between MRI utilization and DMT switch among people with MS in the United States H Naizer, III, H. Kohl, TM Krause, R Hamden, J Wozny, O Charron, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 661-662, 2022 | | 2022 |
| COVID-19 Vaccination Intent and Uptake in People with MS: A Longitudinal Survey Study O Charron, K Onuorah, HMO Onuorah, A Montague, A Crispino, ... 2022 Annual Meeting of the Consortium of Multiple Sclerosis Centers, 2022 | | 2022 |
| Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of MS DMTs: A Systematic Review (P4-4.011) H Onuorah, O Charron, E Meltzer, A Montague, A Crispino, A Largent, ... Neurology 98 (18 Supplement), 2022 | | 2022 |
| Impact of the COVID-19 pandemic on disease-modifying therapy utilization and perceptions in multiple sclerosis: A retrospective insurance claims analysis and survey study of … E Meltzer, O Charron, R Hamden, H Onuorah, A Montague, A Crispino, ... Multiple Sclerosis Journal, 547-547, 2021 | | 2021 |
| Impact of the COVID-19 pandemic on healthcare access and perceived outcomes: A survey study of people with MS in the United States O Charron, H Onuorah, A Montague, A Crispino, A Lucas, E Meltzer, ... Multiple Sclerosis Journal, 686-687, 2021 | | 2021 |
| Racial inequalities in multiple sclerosis research participation: underreporting and underrepresentation H Onuorah, A Lucas, O Charron, A Montague, A Crispino, A Aguirre, ... MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 320-320, 2020 | | 2020 |
| Microglia activation in basal ganglia is a late event in Huntington’s disease pathophysiology (2626) E Furr-Stimming, L Latham, O Charron, G Colpo, P Zanotti-Freganaro, ... Neurology 94 (15 Supplement), 2020 | | 2020 |
| Subcortical atrophy is an early event in Huntington's disease N Rocha, L Latham, O Charron, G Papadimitropoulos, G Colpo, ... MOVEMENT DISORDERS 34, S19-S20, 2019 | | 2019 |
| Microglia Activation in Basal Ganglia Is a Late Event in Huntington's Disease Pathophysiology NP Rocha, LB Latham, O Charron, GD Colpo, P Zanotti-Fregonara, ... NEUROTHERAPEUTICS 16 (4), 1377-1377, 2019 | | 2019 |
| Exploring the relationship between brain atrophy and clinical symptoms in Huntington’s disease (S41. 009) E Furr-Stimming, G Colpo, NP Rocha, L Latham, O Charron, ... Neurology 92 (15 Supplement), 2019 | | 2019 |
| Decreased cerebral blood flow in the striatum is an early event in Huntington’s disease pathology (P1. 8-044) E Furr-Stimming, NP Rocha, L Latham, O Charron, G Papadimitropoulos, ... Neurology 92 (15 Supplement), 2019 | | 2019 |
| Multi-Class Segmentation of Multiple Sclerosis Lesions Using Convolutional Neural Networks in the Combirx Cohort O Charron, N Moll, G Papadimitropoulos, K Wahid, JA Lincoln, SS Cofield, ... ACTRIMS Forum 2019, 2019 | | 2019 |
Natalia Pessoa RochaAssistant Professor, The University of Texas Health Science Center at HoustonVerified email at uth.tmc.edu
